Clinical Trial Update: Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the nonavalent HPV vaccine (Gardasil 9) for the treatment of difficult-to-treat palmar and plantar warts and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Verruca Palmaris
• Verruca Plantaris

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Palmar or Plantar Warts | Phase 3 | Status: RECRUITING